Center Partnerships Diabetes Research Centers now highlights DRC Partner Institutions. Center partnerships are listed with location details and links to the partnership website. An overview of the partner institution and its research centers, institutions, and programs can also be viewed.

DIABETES RESEARCH CENTERS

Hassan Chaib Hassan Chaib PhD Stanford University Stanford University
In 2011, Dr. Chaib joined the Genetics Department at Stanford University, focusing on next generation sequencing technologies and stem cell therapy of muscular dystrophy. He is currently the Director of Lab Operations for SCGPM and the GSSC and Director of Stem Cell Genomics at the CIRM CESCG. The mission of the Stanford Diabetes Research Center is to support basic and clinical research to discover, apply and translate science about diabetes and it complications, to improve health and wellness.
Julian P Whitelegge Julian P Whitelegge PhD UCSD-UCLA UCSD-UCLA
Julian Whitelegge received his Ph.D. from Imperial College of Science and Technology, University of London in 1989 and became heavily involved in mass spectrometry research in the mid nineties. The overall mission of the UCSD-UCLA DRC is to foster research in theprevention and treatment of diabetes and its complications, and to improve the lives of patients suffering from this devastating disease.
Jerrold M Olefsky Jerrold M Olefsky MD UCSD-UCLA UCSD-UCLA
My research program is divided into clinical investigation and basic research components. Clinical investigation approaches include studies aimed at identifying in vivo mechanisms underlying the pathogenesis of non-insulin dependent diabetes mellitus, obesity, and other disorders of insulin resistance. The overall mission of the UCSD-UCLA DRC is to foster research in theprevention and treatment of diabetes and its complications, and to improve the lives of patients suffering from this devastating disease.
George L King George L King MD Joslin Diabetes Center Joslin Diabetes Center
My laboratory studies the mechanism by which hyperglycemia and insulin resistance are causing diabetic retinopathy, nephropathy and cardiovascular diseases. Since its inception in 1898, the primary mission of the Joslin Diabetes Center has been to care for people with diabetes, and conduct research to provide new knowledge about diabetes and its complications that will lead to new treatments, prevention and/or cure of these disorders.
Kieren Mather Kieren Mather MD Indiana University Indiana University
Dr Mather’s research focuses on metabolic dysfunction in diabetes and pre diabetic obesity in humans, and how this metabolic dysfunction influences cardiac and vascular function. The Center for Diabetes and Metabolic Diseases (CDMD) at IU School of Medicine is a world-renowned center focused on centralizing and fostering research along five fundamental themes to strengthen the diabetes research base throughout Indiana.
Jay Heinecke Jay Heinecke MD University of Washington University of Washington
The major focus of research in the Heinecke laboratory is to understand the role of HDL and macrophages in the pathogenesis of atherosclerosis, diabetes and other inflammatory diseases The University of Washington (UW) Diabetes Research Center (DRC) at the University of Washington is one of 16 Diabetes Research Centers sponsored by the National Institutes of Health to promote basic, translational, and clinical research on diabetes and related metabolic disorders.
Laurie J Goodyear Laurie J Goodyear PhD MS Joslin Diabetes Center Joslin Diabetes Center
Work in the Goodyear lab has uncovered many of the basic mechanisms that underlie the effects of exercise on metabolism, and has successfully translated many of these findings into humans. Since its inception in 1898, the primary mission of the Joslin Diabetes Center has been to care for people with diabetes, and conduct research to provide new knowledge about diabetes and its complications that will lead to new treatments, prevention and/or cure of these disorders.
Alan R Saltiel Alan R Saltiel PhD UCSD-UCLA UCSD-UCLA
Dr. Alan Saltiel investigates the hormone insulin and its role in regulating cellular sugar levels, including how cells send and receive signals. Understanding these processes may shed light on dysfunctioning glucose and lipid metabolism, particularly as it related to Type 2 diabetes. The overall mission of the UCSD-UCLA DRC is to foster research in theprevention and treatment of diabetes and its complications, and to improve the lives of patients suffering from this devastating disease.
Amy Wagers Amy Wagers PhD Joslin Diabetes Center Joslin Diabetes Center
Work in Amy Wagers' laboratory focuses on defining how changes in stem cell activity impact tissue regeneration throughout life and identifying the physiological and pathological signals that modulate stem cell function in an age-dependent manner. Since its inception in 1898, the primary mission of the Joslin Diabetes Center has been to care for people with diabetes, and conduct research to provide new knowledge about diabetes and its complications that will lead to new treatments, prevention and/or cure of these disorders.
David P Olson David P Olson MD PhD University of Michigan University of Michigan
Using novel mouse models, Dr. Olson is exploring gene expression changes in specific neuronal populations in the brain that are known to be important in regulating energy balance; these studies are directed at examining the link between gene expression in specific areas of the brain and altered metabolism. The goal of the Michigan Diabetes Research Center (MDRC) is to establish, promote, and enhance multidisciplinary and collaborative basic biomedical and clinical research among member investigators studying diabetes, its complications, and related endocrine and metabolic disorders.
Michael German Michael German MD UCSF UCSF
Dr. German is the Associate Director and Clinical Director of the UCSF Diabetes Center, Director of the the Hillblom Islet Genesis Network and the UCSF NIH Diabetes Research Center (DRC). The University of California San Francisco Diabetes Research Center (UCSF DRC) is one of only 16 research centers established by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to accelerate basic and clinical research into diabetes.
Stephen A Liebhaber MD University of Pennsylvania University of Pennsylvania
Dr. Liebhaber's research interests are the roles of chromatin structure and epigenetic controls in eucaryotic gene activation and mRNA-protein interactions in control of eucarytic mRNA stability and expression. The Penn Diabetes Research Center participates in the nationwide inter-disciplinary program established over forty years ago by the NIDDK to foster research and training in the areas of diabetes and related endocrine and metabolic disorders.
K Sam Wells K Sam Wells PhD Vanderbilt University Vanderbilt University
Dr. Wells obtained a Ph.D. in Physical Chemistry studying the experimental and theoretical optical physics of polarized light scattering and absorbance in condensed materials, including the development of imaging of such processes. The Vanderbilt Diabetes Research and Training Center (DRTC), is a NIH-sponsored Diabetes Center that facilitates the discovery, application, and translation of scientific knowledge to improve the lives of people with diabetes.
William Herman William Herman MD University of Michigan University of Michigan
Dr. William Herman received his medical degree from Boston University in 1979. He completed an internship and residency in Internal Medicine at the University of Michigan. Dr Herman's past and present research has focused on clinical, epidemiologic, and health services research in diabetes. The goal of the Michigan Diabetes Research Center (MDRC) is to establish, promote, and enhance multidisciplinary and collaborative basic biomedical and clinical research among member investigators studying diabetes, its complications, and related endocrine and metabolic disorders.
William V Tamborlane William V Tamborlane MD Yale University Yale University
William V. Tamborlane, MD, is a graduate of Georgetown University School of Medicine, where he completed his residency in pediatrics before going to Yale as a postdoctoral fellow in pediatric endocrinology. The Yale Diabetes Research Center (DRC) was established in the spring of 1993 with the goal of promoting research in diabetes and related metabolic and endocrine disorders at the university.
Michael McManus PhD UCSF UCSF
The McManus lab studies fundamental processes relating to mammalian gene expression. We take high-throughput approaches, analyzing hundreds of thousands to millions of experiments at once, using complex libraries coupled to deep sequencing. The University of California San Francisco Diabetes Research Center (UCSF DRC) is one of only 16 research centers established by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to accelerate basic and clinical research into diabetes.

Diabetes Centers Overview

Diabetes Centers

NIDDK Diabetes Centers

The NIDDK-supported Diabetes Research Centers (DRCs) are part of an integrated program of diabetes and related endocrinology and metabolism research. NIDDK’s Diabetes Centers program supports extramural research institutions that have established an existing base of high-quality, diabetes-related research. Centers provide increased, cost effective collaboration among multidisciplinary groups of investigators at institutions with an established, comprehensive research base in diabetes and related areas of endocrinology and metabolism. DRCs are intended to improve the quality and multidisciplinary nature of research on diabetes by providing shared access to specialized technical resources and expertise. DRCs are intended to facilitate progress in research with the goal of developing new methods to treat, prevent and ultimately cure diabetes mellitus and its complications.

In the Spotlight

Pilot & Feasibility Study
Center Publication
University of Pennsylvania Penn Albert Einstein College of Medicine Einstein 
Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice., Beckerman, Pazit, Bi-Karchin Jing, Park Ae Seo Deok, Qiu Chengxiang, Dummer Patrick D., Soomro Irfana, Boustany-Kari Carine M., Pullen Steven S., Miner Jeffrey H., Hu Chien-An A., et al. , Nat Med, 2017 Apr, Volume 23, Issue 4, p.429-438, (2017)
NIDDK Center
The mission of the National Mouse Metabolic Phenotyping Centers is to advance medical and biological research by providing the scientific community with standardized, high quality metabolic and physiologic phenotyping services for mouse models of diabetes, diabetic complications, obesity and related disorders.
Diabetes Resource
The NIDDK Information Network (dkNET), is a search portal and information hub that helps researchers find research resources and data repositories relevant to their research and keep up to date on new tools, services and mandates to support robust and reproducible science, including funding opportunities, resource authentication and data sharing.